Primary Biliary Cholangitis Clinical Trials

Find Primary Biliary Cholangitis Clinical Trials Near You

An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects With Primary Biliary Cholangitis (PBC)

Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 2/Phase 3
SUMMARY

An Open Label Long-Term Study to Evaluate the Safety and Effectiveness of Fenofibrate in Subjects with Primary Biliary Cholangitis (PBC)

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

• Must have given written informed consent (signed and dated)

• Participated in the PBC study with fenofibrate (NCT02823353)

• Females of reproductive potential must use at least one barrier contraceptive and a second effective birth control method during the study and for at least 90 days after the last dose. Male subjects who are sexually active with female partners of reproductive potential must use barrier contraception and their female partners must use a second effective birth control method during the study and for at least 90 days after the last dose

Locations
Other Locations
China
Xijing Hospital
RECRUITING
Xi'an
Contact Information
Primary
Yansheng Liu, MD
liuyansheng506@163.com
+862984771539
Time Frame
Start Date: 2017-04-08
Estimated Completion Date: 2027-04
Participants
Target number of participants: 117
Treatments
Active_comparator: UDCA
Experimental: UDCA+Fenofibrate
Sponsors
Leads: Xijing Hospital of Digestive Diseases

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.